These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29143216)

  • 21. Ganglion cell-inner plexiform layer and retinal nerve fibre layer changes within the macula in retinitis pigmentosa: a spectral domain optical coherence tomography study.
    Yoon CK; Yu HG
    Acta Ophthalmol; 2018 Mar; 96(2):e180-e188. PubMed ID: 29098796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?
    Sabadia SB; Nolan RC; Galetta KM; Narayana KM; Wilson JA; Calabresi PA; Frohman EM; Galetta SL; Balcer LJ
    J Neuroophthalmol; 2016 Dec; 36(4):369-376. PubMed ID: 27472185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual Impairments Are Associated With Retinal Microvascular Density in Patients With Parkinson's Disease.
    Zhou M; Wu L; Hu Q; Wang C; Ye J; Chen T; Wan P
    Front Neurosci; 2021; 15():718820. PubMed ID: 34475812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.
    Ekici F; Loh R; Waisbourd M; Sun Y; Martinez P; Nayak N; Wizov SS; Hegarty S; Hark LA; Spaeth GL
    JAMA Ophthalmol; 2015 Dec; 133(12):1377-85. PubMed ID: 26425961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distorted colour discrimination in Parkinson's disease is related to severity of the disease.
    Müller T; Kuhn W; Büttner T; Przuntek H
    Acta Neurol Scand; 1997 Nov; 96(5):293-6. PubMed ID: 9404998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.
    Yuksel B; Dogan B; Koctekin B; Atis N; Erdal A; Kurtulus F; Erol MK; Gomceli YB
    J Clin Neurosci; 2019 Mar; 61():48-53. PubMed ID: 30455132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
    Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C
    Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
    Satue M; Rodrigo MJ; Otin S; Bambo MP; Fuertes MI; Ara JR; Martin J; Polo V; Larrosa JM; Pablo L; Garcia-Martin E
    PLoS One; 2016; 11(6):e0157293. PubMed ID: 27351450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased color discrimination and contrast sensitivity in Parkinson's disease.
    Pieri V; Diederich NJ; Raman R; Goetz CG
    J Neurol Sci; 2000 Jan; 172(1):7-11. PubMed ID: 10620653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life.
    Prager AJ; Hood DC; Liebmann JM; De Moraes CG; Al-Aswad LA; Yu Q; Cioffi GA; Blumberg DM
    JAMA Ophthalmol; 2017 Jul; 135(7):783-788. PubMed ID: 28594977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of levodopa on retina in Parkinson disease.
    Sen A; Tugcu B; Coskun C; Ekinci C; Nacaroglu SA
    Eur J Ophthalmol; 2014; 24(1):114-9. PubMed ID: 23828323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Color vision in Parkinson's disease: missing influence of amantadine sulphate.
    Büttner T; Kuhn W; Müller T; Patzold T; Przuntek H
    Clin Neuropharmacol; 1995 Oct; 18(5):458-63. PubMed ID: 8665560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino Eye Study.
    Globe DR; Wu J; Azen SP; Varma R;
    Ophthalmology; 2004 Jun; 111(6):1141-9. PubMed ID: 15177964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
    Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson's disease.
    Unlu M; Gulmez Sevim D; Gultekin M; Karaca C
    Neurol Sci; 2018 Mar; 39(3):533-541. PubMed ID: 29349656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
    Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
    Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson's disease.
    Sun L; Zhang H; Gu Z; Cao M; Li D; Chan P
    Eur J Med Res; 2014 May; 19(1):29. PubMed ID: 24886673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
    Nousiainen I; Kälviäinen R; Mäntyjärvi M
    Ophthalmology; 2000 May; 107(5):884-8. PubMed ID: 10811079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Color vision defects in sickle cell anemia.
    Roy MS; Rodgers G; Gunkel R; Noguchi C; Schechter A
    Arch Ophthalmol; 1987 Dec; 105(12):1676-8. PubMed ID: 3500701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
    Nowacka B; Lubiński W; Honczarenko K; Potemkowski A; Safranow K
    Doc Ophthalmol; 2015 Oct; 131(2):95-104. PubMed ID: 25972299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.